ArticleJournal of cellular and molecular medicine2021

MET inhibition enhances PARP inhibitor efficacy in castration-resistant prostate cancer by suppressing the ATM/ATR and PI3K/AKT pathways.

Sihai Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.